Skip to main content

Clinical TrialsSearch 1M+ trials from global registries Drug IntelligenceFollow pipelines from discovery to approval

Global ApprovalsTrack regulatory decisions across 12+ agencies

US FDA Drugs EU EMA Drugs Singapore HSA Drugs China NMPA Drugs Australia TGA Drugs Canada HC Drugs Spain CIMA-AEMPS Drugs UK EMC Drugs Saudi SFDA Drugs Malaysia NPRA Drugs Philippines FDA Drugs Kenya PPB Drugs

AI-Powered ResearchDiscover powerful insights with advanced AI analysis tools for clinical trials.Learn more →Premium AccessGet unlimited access to our comprehensive pharmaceutical database and analytics.Subscribe →

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

PALAVO SUSPENSION 120MG/5ML - HSA Drug Approval Details

Approvals/HSA/PALAVO SUSPENSION 120MG/5ML

Approved

THERAPEUTIC

PALAVO SUSPENSION 120MG/5ML

XEPA-SOUL PATTINSON (M) SDN BHD🇸🇬 Health Sciences Authority

Approval Date: Apr 2, 2025
Approval ID: 2296e8f037f1b750
Company: XEPA-SOUL PATTINSON (M) SDN BHD
Type: Therapeutic

Approval Details

Approval Id: 2296e8f037f1b750
Drug Name: PALAVO SUSPENSION 120MG/5ML
Product Name: PALAVO SUSPENSION 120MG/5ML
Approval Number: SIN17213P
Approval Date: 2025-04-02
Registrant: APEX PHARMA MARKETING PTE. LTD.
Drug Type: Therapeutic
Forensic Classification: General Sale List
Dosage Form: SUSPENSION
Route Of Administration: ORAL
Atc Code: N02BE01
Pharma Manufacturer Name: APEX PHARMA MARKETING PTE. LTD.
Company Detail Path: /organization/f3877d86bd1d513a/apex-pharma-marketing-pte-ltd

Active Ingredients

PARACETAMOL

120MG/5ML

PARACETAMOL

120MG/5ML

Approved

Quick Info

Agency

HSA

Country

🇸🇬

Approval Date

Apr 2, 2025

Approval ID

2296e8f037f1b750

Type

Therapeutic

Back to HSA Approvals